newsfilter
← Latest News
Business Wire·

Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.

Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company committed to improving the lives of patients with seizure disorders, today